S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.44 (+0.43%)
AAPL   176.86 (+1.18%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.75 (+0.38%)
AMZN   131.18 (+1.60%)
TSLA   246.75 (+0.76%)
NVDA   421.82 (+1.37%)
NIO   8.40 (-1.52%)
BABA   87.14 (-1.31%)
AMD   97.01 (+0.84%)
T   15.03 (-0.60%)
F   12.68 (+2.01%)
MU   68.58 (-0.44%)
CGC   1.00 (+18.92%)
GE   111.63 (+0.34%)
DIS   80.85 (-0.49%)
AMC   8.30 (+8.92%)
PFE   32.75 (+0.18%)
PYPL   58.39 (+0.88%)
NFLX   382.93 (+0.82%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.44 (+0.43%)
AAPL   176.86 (+1.18%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.75 (+0.38%)
AMZN   131.18 (+1.60%)
TSLA   246.75 (+0.76%)
NVDA   421.82 (+1.37%)
NIO   8.40 (-1.52%)
BABA   87.14 (-1.31%)
AMD   97.01 (+0.84%)
T   15.03 (-0.60%)
F   12.68 (+2.01%)
MU   68.58 (-0.44%)
CGC   1.00 (+18.92%)
GE   111.63 (+0.34%)
DIS   80.85 (-0.49%)
AMC   8.30 (+8.92%)
PFE   32.75 (+0.18%)
PYPL   58.39 (+0.88%)
NFLX   382.93 (+0.82%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.44 (+0.43%)
AAPL   176.86 (+1.18%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.75 (+0.38%)
AMZN   131.18 (+1.60%)
TSLA   246.75 (+0.76%)
NVDA   421.82 (+1.37%)
NIO   8.40 (-1.52%)
BABA   87.14 (-1.31%)
AMD   97.01 (+0.84%)
T   15.03 (-0.60%)
F   12.68 (+2.01%)
MU   68.58 (-0.44%)
CGC   1.00 (+18.92%)
GE   111.63 (+0.34%)
DIS   80.85 (-0.49%)
AMC   8.30 (+8.92%)
PFE   32.75 (+0.18%)
PYPL   58.39 (+0.88%)
NFLX   382.93 (+0.82%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.44 (+0.43%)
AAPL   176.86 (+1.18%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.75 (+0.38%)
AMZN   131.18 (+1.60%)
TSLA   246.75 (+0.76%)
NVDA   421.82 (+1.37%)
NIO   8.40 (-1.52%)
BABA   87.14 (-1.31%)
AMD   97.01 (+0.84%)
T   15.03 (-0.60%)
F   12.68 (+2.01%)
MU   68.58 (-0.44%)
CGC   1.00 (+18.92%)
GE   111.63 (+0.34%)
DIS   80.85 (-0.49%)
AMC   8.30 (+8.92%)
PFE   32.75 (+0.18%)
PYPL   58.39 (+0.88%)
NFLX   382.93 (+0.82%)
OTCMKTS:CZMWY

Carl Zeiss Meditec (CZMWY) Stock Forecast, Price & News

$86.49
+1.14 (+1.33%)
(As of 09/22/2023 08:53 PM ET)
Compare
Today's Range
$85.69
▼
$87.27
50-Day Range
$85.35
▼
$115.64
52-Week Range
$84.91
▼
$153.84
Volume
10,500 shs
Average Volume
2,633 shs
Market Capitalization
N/A
P/E Ratio
94.01
Dividend Yield
0.35%
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsDividendHeadlinesShort Interest

Carl Zeiss Meditec MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Carl Zeiss Meditec in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.03 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CZMWY stock logo

About Carl Zeiss Meditec (OTCMKTS:CZMWY) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

CZMWY Price History

CZMWY Stock News Headlines

September 23, 2023 | fool.com
Carl Zeiss Meditec Ag (ETR: AFX)
September 23, 2023 | americanbankingnews.com
Contrasting Carl Zeiss Meditec (OTCMKTS:CZMWY) and Fisher & Paykel Healthcare (OTCMKTS:FSPKF)
September 25, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
September 17, 2023 | americanbankingnews.com
Critical Comparison: Carl Zeiss Meditec (CZMWY) & The Competition
September 5, 2023 | finance.yahoo.com
Estimating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
August 8, 2023 | msn.com
Carl Zeiss Meditec: One Of The Highest Premiums I'll Accept
July 28, 2023 | seekingalpha.com
CZMWF Carl Zeiss Meditec AG
July 4, 2023 | finance.yahoo.com
There's Been No Shortage Of Growth Recently For Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
September 25, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
June 16, 2023 | fool.com
Carl Zeiss Meditec Ag (OTC: CZMWF)
June 6, 2023 | finance.yahoo.com
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
April 12, 2023 | finance.yahoo.com
Institutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the company
February 19, 2023 | finance.yahoo.com
Carl Zeiss Meditec First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
February 3, 2023 | markets.businessinsider.com
EQS-AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
January 20, 2023 | finance.yahoo.com
Carl Zeiss Meditec (ETR:AFX) Is Increasing Its Dividend To €1.10
January 12, 2023 | finance.yahoo.com
Carl Zeiss Meditec (ETR:AFX) Might Have The Makings Of A Multi-Bagger
December 28, 2022 | finance.yahoo.com
Carl Zeiss Meditec AG's (ETR:AFX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
December 12, 2022 | finance.yahoo.com
Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
December 9, 2022 | technews.tmcnet.com
ZEISS Academy Africa inaugurated
November 12, 2022 | seekingalpha.com
CZMWY Carl Zeiss Meditec AG
May 14, 2022 | markets.businessinsider.com
What Wall Street expects from Carl Zeiss Meditec's earnings
February 13, 2022 | uk.finance.yahoo.com
Carl Zeiss Meditec achieves further growth in first quarter of 2021/22
February 13, 2022 | markets.businessinsider.com
Carl Zeiss Meditec earnings preview: what Wall Street is expecting
December 12, 2021 | uk.finance.yahoo.com
Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
December 10, 2021 | seekingalpha.com
Carl Zeiss Meditec AG 2021 Q1 - Results - Earnings Call Presentation
October 2, 2021 | uk.finance.yahoo.com
Change to Executive Board of Carl Zeiss Meditec AG
September 30, 2021 | uk.finance.yahoo.com
Leadership Change in the Executive Board of Carl Zeiss Meditec AG
See More Headlines
Receive CZMWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CZMWY
CUSIP
N/A
CIK
N/A
Web
www.zeiss.com
Phone
493641220115
Fax
N/A
Employees
4,224
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
94.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Markus Weber
    CEO & Chairman of Management Board
  • Mr. Justus Felix Wehmer (Age 58)
    CFO & Member of the Management Board
    Comp: $635.31k
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D. (Age 60)
    Pres of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Bus. Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Bus. Unit - ZEISS Medical Technology
  • Dr. Christian Munster (Age 52)
    Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board

Key Competitors

View All Competitors













CZMWY Stock - Frequently Asked Questions

Should I buy or sell Carl Zeiss Meditec stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CZMWY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CZMWY, but not buy additional shares or sell existing shares.
View CZMWY analyst ratings or view top-rated stocks.

How have CZMWY shares performed in 2023?

Carl Zeiss Meditec's stock was trading at $126.09 on January 1st, 2023. Since then, CZMWY stock has decreased by 31.4% and is now trading at $86.4850.
View the best growth stocks for 2023 here.

Are investors shorting Carl Zeiss Meditec?

Carl Zeiss Meditec saw a increase in short interest in August. As of August 31st, there was short interest totaling 1,800 shares, an increase of 350.0% from the August 15th total of 400 shares. Based on an average daily volume of 18,600 shares, the short-interest ratio is presently 0.1 days.
View Carl Zeiss Meditec's Short Interest.

How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec?

Carl Zeiss Meditec declared a dividend on Friday, March 17th. Stockholders of record on Friday, March 24th will be paid a dividend of $0.8144 per share on Tuesday, April 11th. This represents a dividend yield of 0.56%. The ex-dividend date is Thursday, March 23rd. This is a boost from the stock's previous dividend of $0.68.
Read our dividend analysis for CZMWY.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CZMWY.

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the OTCMKTS under the ticker symbol "CZMWY."

How do I buy shares of Carl Zeiss Meditec?

Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Carl Zeiss Meditec's stock price today?

One share of CZMWY stock can currently be purchased for approximately $86.49.

How many employees does Carl Zeiss Meditec have?

The company employs 4,224 workers across the globe.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, Jena, Thueringen 07745. The official website for the company is www.zeiss.com. The company can be reached via phone at 493641220115.

This page (OTCMKTS:CZMWY) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -